CIK 0001833214
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853899721
- Phone
- +1 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-16 | Finnegan Frederick Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +23,453 | 23,453 | ||
| 2021-10-22 | Finnegan Frederick Chief Business Officer | Grant or award | +38,596 | 38,596 | ||
| 2021-10-22 | Finnegan Frederick Chief Business Officer | Grant or award · Earnout Rights (Common Stock) | +15,593 | 15,593 | ||
| 2021-10-22 | Finnegan Frederick Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +23,264 | 23,264 | ||
| 2021-10-22 | Finnegan Frederick Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +125,627 | 125,627 | ||
| 2021-10-22 | Finnegan Frederick Chief Business Officer | Grant or award · Earnout Rights (Restricted Stock Units) | +60,152 | 60,152 |
Page 1 of 1 · 6 trades